228 related articles for article (PubMed ID: 36498921)
1. MIG-6 Is Critical for Progesterone Responsiveness in Human Complex Atypical Hyperplasia and Early-Stage Endometrial Cancer.
Jeong O; Broaddus RR; Lessey BA; Risinger JI; Hunter MI; Kim TH
Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36498921
[TBL] [Abstract][Full Text] [Related]
2. MIG-6 negatively regulates STAT3 phosphorylation in uterine epithelial cells.
Yoo JY; Yang WS; Lee JH; Kim BG; Broaddus RR; Lim JM; Kim TH; Jeong JW
Oncogene; 2018 Jan; 37(2):255-262. PubMed ID: 28925396
[TBL] [Abstract][Full Text] [Related]
3. MIG-6 suppresses endometrial epithelial cell proliferation by inhibiting phospho-AKT.
Yoo JY; Kang HB; Broaddus RR; Risinger JI; Choi KC; Kim TH
BMC Cancer; 2018 May; 18(1):605. PubMed ID: 29843645
[TBL] [Abstract][Full Text] [Related]
4. Mig-6 modulates uterine steroid hormone responsiveness and exhibits altered expression in endometrial disease.
Jeong JW; Lee HS; Lee KY; White LD; Broaddus RR; Zhang YW; Vande Woude GF; Giudice LC; Young SL; Lessey BA; Tsai SY; Lydon JP; DeMayo FJ
Proc Natl Acad Sci U S A; 2009 May; 106(21):8677-82. PubMed ID: 19439667
[TBL] [Abstract][Full Text] [Related]
5. Critical tumor suppressor function mediated by epithelial Mig-6 in endometrial cancer.
Kim TH; Lee DK; Cho SN; Orvis GD; Behringer RR; Lydon JP; Ku BJ; McCampbell AS; Broaddus RR; Jeong JW
Cancer Res; 2013 Aug; 73(16):5090-9. PubMed ID: 23811943
[TBL] [Abstract][Full Text] [Related]
6. Mig-6 Mouse Model of Endometrial Cancer.
Kim TH; Yoo JY; Jeong JW
Adv Exp Med Biol; 2017; 943():243-259. PubMed ID: 27910070
[TBL] [Abstract][Full Text] [Related]
7. A calcium-dependent phospholipase A2 (cPLA2) expression is regulated by MIG-6 during endometrial tumorigenesis.
Teasley HE; Jeong MP; Kim TH
Biochem Biophys Res Commun; 2019 Mar; 511(1):129-134. PubMed ID: 30773264
[TBL] [Abstract][Full Text] [Related]
8. Mig-6 regulates endometrial genes involved in cell cycle and progesterone signaling.
Yoo JY; Kim TH; Lee JH; Dunwoodie SL; Ku BJ; Jeong JW
Biochem Biophys Res Commun; 2015 Jul; 462(4):409-14. PubMed ID: 25976672
[TBL] [Abstract][Full Text] [Related]
9. Prospective phase II trial of levonorgestrel intrauterine device: nonsurgical approach for complex atypical hyperplasia and early-stage endometrial cancer.
Westin SN; Fellman B; Sun CC; Broaddus RR; Woodall ML; Pal N; Urbauer DL; Ramondetta LM; Schmeler KM; Soliman PT; Fleming ND; Burzawa JK; Nick AM; Milbourne AM; Yuan Y; Lu KH; Bodurka DC; Coleman RL; Yates MS
Am J Obstet Gynecol; 2021 Feb; 224(2):191.e1-191.e15. PubMed ID: 32805208
[TBL] [Abstract][Full Text] [Related]
10. Tumor-associated macrophages correlate with progesterone receptor loss in endometrial endometrioid adenocarcinoma.
Jiang XF; Tang QL; Li HG; Shen XM; Luo X; Wang XY; Lin ZQ
J Obstet Gynaecol Res; 2013 Apr; 39(4):855-63. PubMed ID: 23106983
[TBL] [Abstract][Full Text] [Related]
11. Loss of MIG-6 results in endometrial progesterone resistance via ERBB2.
Yoo JY; Kim TH; Shin JH; Marquardt RM; Müller U; Fazleabas AT; Young SL; Lessey BA; Yoon HG; Jeong JW
Nat Commun; 2022 Mar; 13(1):1101. PubMed ID: 35232969
[TBL] [Abstract][Full Text] [Related]
12. Upregulation of mitogen-inducible gene 6 triggers antitumor effect and attenuates progesterone resistance in endometrial carcinoma cells.
Xu W; Zhu S; Zhou Y; Jin Y; Dai H; Wang X
Cancer Gene Ther; 2015 Nov; 22(11):536-41. PubMed ID: 26450625
[TBL] [Abstract][Full Text] [Related]
13. Coordinate expression of Cdc25B and ER-alpha is frequent in low-grade endometrioid endometrial carcinoma but uncommon in high-grade endometrioid and nonendometrioid carcinomas.
Wu W; Slomovitz BM; Celestino J; Chung L; Thornton A; Lu KH
Cancer Res; 2003 Oct; 63(19):6195-9. PubMed ID: 14559803
[TBL] [Abstract][Full Text] [Related]
14. Loss of ARID1A expression in endometrial samplings is associated with the risk of endometrial carcinoma.
Yen TT; Miyamoto T; Asaka S; Chui MH; Wang Y; Lin SF; Stone RL; Fader AN; Asaka R; Kashima H; Shiozawa T; Wang TL; Shih IM; Tanner EJ
Gynecol Oncol; 2018 Sep; 150(3):426-431. PubMed ID: 30126589
[TBL] [Abstract][Full Text] [Related]
15. [Effects of pathological assessment of endometrial tissue in fertility-sparing treatment with progestin for endometrial carcinoma of stage I a and complex atypical hyperplasia].
Gong Q; Chen X; Xie X
Zhonghua Fu Chan Ke Za Zhi; 2014 Sep; 49(9):664-9. PubMed ID: 25487452
[TBL] [Abstract][Full Text] [Related]
16. ARID1A Regulates Progesterone Receptor Expression in Early Endometrial Endometrioid Carcinoma Pathogenesis.
Asaka S; Liu Y; Yu ZC; Rahmanto YS; Ono M; Asaka R; Miyamoto T; Yen TT; Ayhan A; Wang TL; Shih IM
Mod Pathol; 2023 Feb; 36(2):100045. PubMed ID: 36853791
[TBL] [Abstract][Full Text] [Related]
17. Uterine Epithelial Progesterone Receptor Governs Uterine Receptivity Through Epithelial Cell Differentiation.
Gebril M; Hirota Y; Aikawa S; Fukui Y; Kaku T; Matsuo M; Hirata T; Akaeda S; Hiraoka T; Shimizu-Hirota R; Takeda N; Taha T; Balah OA; Elnoury MAH; Fujii T; Osuga Y
Endocrinology; 2020 Dec; 161(12):. PubMed ID: 33099617
[TBL] [Abstract][Full Text] [Related]
18. DNMT3A/3B overexpression might be correlated with poor patient survival, hypermethylation and low expression of ESR1/PGR in endometrioid carcinoma: an analysis of The Cancer Genome Atlas.
He D; Wang X; Zhang Y; Zhao J; Han R; Dong Y
Chin Med J (Engl); 2019 Jan; 132(2):161-170. PubMed ID: 30614867
[TBL] [Abstract][Full Text] [Related]
19. The synergistic effect of Mig-6 and Pten ablation on endometrial cancer development and progression.
Kim TH; Franco HL; Jung SY; Qin J; Broaddus RR; Lydon JP; Jeong JW
Oncogene; 2010 Jul; 29(26):3770-80. PubMed ID: 20418913
[TBL] [Abstract][Full Text] [Related]
20. Endometrial Cancer Following Levonorgestrel-Releasing Intrauterine System Insertion in Young Women with Atypical Hyperplasia: Two Case Reports and Literature Review.
Peng H; Jiang J; Li X
Reprod Sci; 2022 Nov; 29(11):3278-3284. PubMed ID: 35641856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
